Aptevo Therapeutics Inc [NASDAQ: APVO] closed the trading session at $0.96. The company report on April 11, 2024 at 8:00 AM that Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering. Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics
Aptevo Therapeutics Inc [NASDAQ: APVO] traded at a high on Thursday, posting a 3.12 gain after which it closed the day’ session at $6.60. The company report on March 7, 2024 at 8:55 AM that Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of
Aptevo Therapeutics Inc [NASDAQ: APVO] plunged by -$0.01 during the normal trading session on while it closed the day at $0.15. The company report on November 14, 2023 at 8:05 AM that Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update. The Company’s
© 2024, Powered by Smart TechOne
